Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Lilly, citing FDA feedback, won't seek speedy approval of Alzheimer's drug
BioPharma Dive
Tue, 04/27/21 - 11:25 pm
Tags:
Eli Lilly, Alzheimer's disease, donanemab
Eli Lilly Stock Crumbles As Covid Antibodies Hammer Sales, 2021 Outlook
Investors Business Daily
Tue, 04/27/21 - 10:51 am
Tags:
earnings, Eli Lilly
Lilly scraps IL-23 psoriasis program despite phase 3 success, focuses on IBD race against AbbVie, J&J
Fierce Biotech
Tue, 04/27/21 - 10:50 am
Tags:
Eli Lilly, mirikizumab, psoriasis
The retreat of corporate venture funding?
EP Vantage
Fri, 04/23/21 - 11:02 am
Tags:
funding, venture funding, venture capital, AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GSK, JNJ, Merck, Merck KGaA, Pfizer, Roche, Sanofi, Takeda
Eli Lilly retakes innovation crown, while Bristol Myers rates most inventive pharma in annual study
Fierce Pharma
Thu, 04/22/21 - 11:33 pm
Tags:
Eli Lilly, innovation
Lilly to seek first approval of an autoimmune drug for hair loss
BioPharma Dive
Wed, 04/21/21 - 11:26 pm
Tags:
Eli Lilly, alopecia areata, baricitinib, clinical trials
A new market beckons for Alzheimer’s blood tests
EP Vantage
Mon, 04/19/21 - 11:12 am
Tags:
Alzheimer's disease, diagnostics, donanemab, Eli Lilly, Biogen, Quanterix
Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab
Reuters
Fri, 04/16/21 - 09:48 am
Tags:
Eli Lilly, FDA, antibodies, COVID-19, bamlanivimab
Eli Lilly axes 163 Dermira staffers, shutters Menlo Park site as it closes in around Dupixent rival lebrikizumab
Endpoints
Thu, 04/15/21 - 10:39 am
Tags:
Eli Lilly, Dermira, Qbexza, layoffs
Lilly, Arch join Deerfield in backing new gene therapy biotech Jaguar
BioPharma Dive
Tue, 04/13/21 - 10:14 pm
Tags:
Jaguar Gene Therapy, funding, Eli Lilly, Arch Venture Partners
With variants spreading, Eli Lilly cuts solo COVID-19 antibody out of its U.S. supply deal
Fierce Pharma
Tue, 04/13/21 - 10:35 am
Tags:
Eli Lilly, COVID-19, antibodies, bamlanivimab-etesevimab
5 takeaways from AACR, one of the year's top meetings on cancer drugs
BioPharma Dive
Mon, 04/12/21 - 11:34 pm
Tags:
AACR, CAR-T, Merck, Roche, Sanofi, Synthorx, Eli Lilly, Bristol Myers Squibb
Pharma's pandemic reputation gains score a 'most-improved' medal in annual ranking
Fierce Pharma
Mon, 04/12/21 - 10:58 pm
Tags:
reputation, pharma industry, Sanofi, Novo Nordisk, Roche, Eli Lilly, Bristol Myers Squibb
Lilly gene-targeted drug shows potential for use across cancers
BioPharma Dive
Sun, 04/11/21 - 11:51 pm
Tags:
Eli Lilly, AAACR, Retevmo, cancer, clinical trials
Lilly claims promising finding in failed study of COVID-19 drug
BioPharma Dive
Thu, 04/8/21 - 07:40 pm
Tags:
Eli Lilly, Incyte, COVID-19, baricitinib
Series of JAK inhibitor delays may signal an upcoming FDA adcomm
Endpoints
Thu, 04/8/21 - 11:10 am
Tags:
FDA, JAK inhibitors, AbbVie, Rinvoq, Pfizer, Xeljanz, Eli Lilly, olumiant
FDA pushes eczema decision for Eli Lilly's Olumiant, Pfizer's abrocitinib back 3 months — raising more questions for the JAK class
Endpoints
Wed, 04/7/21 - 10:30 am
Tags:
FDA, JAK inhibitors, Eli Lilly, olumiant, Pfizer, abrocitinib, eczema
Eli Lilly, GlaxoSmithKline-Vir release positive but difficult-to-interpret combo antibody data
Endpoints
Mon, 03/29/21 - 10:52 am
Tags:
Eli Lilly, GSK, Vir Biotechnology, VIR-7831, bamlanivimab, clinical trials, COVID-19
Ex-lobbyist sues Eli Lilly alleging sexual discrimination, harassment
Reuters
Mon, 03/29/21 - 10:47 am
Tags:
Eli Lilly, gender discrimination
FDA Advisory Committee Raises Objections to Pfizer and Eli Lilly’s Tanezumab
BioSpace
Thu, 03/25/21 - 10:47 pm
Tags:
FDA, advisory panels, Pfizer, Eli Lilly, tanezumab, osteoarthritis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.